Plus Therapeutics Stock Math Transform Price Common Logarithm
| PSTV Stock | USD 1.28 0.02 1.59% |
| Symbol |
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Plus Therapeutics Price Common Logarithm is logarithm with base 10 applied on the entire pricing series.
Plus Therapeutics Technical Analysis Modules
Most technical analysis of Plus Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Plus from various momentum indicators to cycle indicators. When you analyze Plus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Plus Therapeutics Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Plus Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Plus Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Plus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Plus Therapeutics's daily price indicators and compare them against related drivers, such as math transform and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Plus Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Plus Therapeutics, we also check how macroeconomic factors affect Plus Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 (projected) | Dividend Yield | 0.002524 | 0.002244 | Price To Sales Ratio | 1.12 | 1.06 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Plus Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Plus Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Plus Therapeutics' short interest history, or implied volatility extrapolated from Plus Therapeutics options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Business Services Invested few shares | |
 | Investor Favorites Invested few shares | |
 | Social Domain Invested few shares | |
 | Macroaxis Picks Invested few shares | |
 | Hedge Favorites Invested over 50 shares | |
 | Warren Buffett Holdings Invested over 60 shares | |
 | Power Assets Invested over 200 shares | |
 | Artificial Intelligence Invested few shares | |
 | FinTech Invested over 40 shares | |
 | Blockchain Invested few shares | |
Additional Tools for Plus Stock Analysis
When running Plus Therapeutics' price analysis, check to measure Plus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Plus Therapeutics is operating at the current time. Most of Plus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Plus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Plus Therapeutics' price. Additionally, you may evaluate how the addition of Plus Therapeutics to your portfolios can decrease your overall portfolio volatility.